KLA stock forecast 2027–2031
Analysts' average 12-month price target for KLA is 219.11, 58.5% above the current price of 138.21. Their targets range from 133.00 to 425.00.
Of the 18 firms that rated KLA in the past 12 months, 14 rate it buy or strong buy, 4 hold and 0 sell or strong sell (each firm at its latest rating): a Buy consensus.
Analysts' 1-year price targets range from 133.00 to 425.00, with an average of 219.11.
| Strong buy | 0 | |
| Buy | 14 | |
| Hold | 4 | |
| Sell | 0 | |
| Strong sell | 0 |
12-month price target
| Highest target | 425.00 |
| Average target | 219.11 |
| Lowest target | 133.00 |
| Current price | 138.21 |
KLA price target history
Have analysts recently raised or lowered their KLA price target and rating?
How analysts rate KLA, month by month
14 of 18 firms rate it buy now, against 12 of 19 in December 2025.
Each month: every firm at its latest rating from the 12 months before. Strong buys count as buys, strong sells as sells.
KLA analyst upgrades, downgrades and price targets
| Date | Firm | Rating | Price target | Change | Price then |
|---|---|---|---|---|---|
| 29 Oct 2026 | Wells Fargo | Reiterated · Overweight | 245.00 → 210.00 | -14.3% | 169.46 |
| 29 Oct 2026 | BMO Capital | — | 133.00 | — | 169.93 |
| 29 Oct 2026 | Cantor Fitzgerald | Reiterated · Overweight | 225.00 → 240.00 | +6.7% | 169.93 |
| 29 Oct 2026 | Piper Sandler | — | 425.00 | — | 169.93 |
| 29 Oct 2026 | Truist Financial | — | 225.00 | — | 169.93 |
| 29 Oct 2026 | Susquehanna Mehdi Hosseini | Reiterated · Neutral | 215.00 → 190.00 | -11.6% | 170.49 |
| 29 Oct 2026 | Morgan Stanley Shane Brett | — | 227.00 → 220.00 | -3.1% | 168.73 |
| 29 Oct 2026 | Cantor Fitzgerald | — | 325.00 → 225.00 | -30.8% | 169.82 |
| 29 Oct 2026 | UBS Timothy Arcuri | Reiterated · Neutral | 200.00 → 180.00 | -10.0% | 158.77 |
| 29 Oct 2026 | Evercore ISI Mark Lipacis | — | 185.00 | — | 158.77 |
| 29 Oct 2026 | Stifel Nicolaus Brian Chin | Reiterated · Buy | 250.00 → 230.00 | -8.0% | 158.77 |
| 29 Oct 2026 | Needham | Reiterated · Buy | 200.00 → 200.00 | 0.0% | 158.77 |
| 6 Oct 2026 | Morgan Stanley | Reiterated · Overweight | 253.00 → 227.00 | -10.3% | 206.85 |
| 1 Sept 2026 | UBS | Reiterated · Neutral | 240.00 → 200.00 | -16.7% | 175.45 |
| 29 Jul 2026 | RBC Capital | Reiterated · Sector Perform | 170.00 → 180.00 | +5.9% | 179.02 |
| 29 Jul 2026 | Susquehanna | Reiterated · Neutral | 275.00 → 215.00 | -21.8% | 190.80 |
| 29 Jul 2026 | Stifel Nicolaus | Reiterated · Buy | 270.00 → 250.00 | -7.4% | 190.80 |
| 29 Jul 2026 | Wells Fargo | Reiterated · Overweight | 305.00 → 245.00 | -19.7% | 190.80 |
| 29 Jul 2026 | Bernstein Stacy Rasgon | — | 187.50 → 225.00 | +20.0% | 190.80 |
| 29 Jul 2026 | Morgan Stanley Shane Brett | — | 274.00 → 253.00 | -7.7% | 190.80 |
| 29 Jul 2026 | Jefferies | Reiterated · Buy | 200.00 → 210.00 | +5.0% | 190.80 |
| 29 Jul 2026 | Deutsche Bank Melissa Weathers | Reiterated · Hold | 175.00 → 195.00 | +11.4% | 190.80 |
| 28 Jul 2026 | Goldman Sachs | — | 145.00 → 230.00 | +58.6% | 190.80 |
| 20 Jul 2026 | UBS Timothy Arcuri | Reiterated · Neutral | 255.00 → 240.00 | -5.9% | 210.16 |
| 20 Jul 2026 | Barclays Tom O'Malley | — | 225.00 → 225.00 | 0.0% | 212.75 |
| 16 Jul 2026 | Oppenheimer Edward Yang | Reiterated · Outperform | 200.00 → 260.00 | +30.0% | 227.91 |
| 15 Jul 2026 | UBS | Reiterated · Neutral | 218.00 → 255.00 | +17.0% | 224.81 |
| 10 Jul 2026 | Stifel Nicolaus | Reiterated · Buy | 170.00 → 270.00 | +58.8% | 229.52 |
| 6 Jul 2026 | Morgan Stanley | Reiterated · Overweight | 190.00 → 274.00 | +44.2% | 242.88 |
| 30 Jun 2026 | Susquehanna | — | 170.00 → 275.00 | +61.8% | 278.39 |
| 29 Jun 2026 | Cantor Fitzgerald | Reiterated · Overweight | 250.00 → 325.00 | +30.0% | 248.64 |
| 22 Jun 2026 | Wells Fargo | Reiterated · Overweight | 190.00 → 305.00 | +60.5% | 259.56 |
| 11 Jun 2026 | Barclays Tom O'Malley | Reiterated · Overweight | 170.00 → 225.00 | +32.4% | 213.56 |
| 10 Jun 2026 | Cantor Fitzgerald | Reiterated · Overweight | 185.00 → 250.00 | +35.1% | 213.94 |
| 10 Jun 2026 | Scotiabank | — | 200.00 | — | 213.94 |
| 9 Jun 2026 | UBS | Reiterated · Neutral | 183.50 → 218.00 | +18.8% | 210.81 |
| 1 May 2026 | Argus Research | — | 140.00 → 195.00 | +39.3% | 173.00 |
| 30 Apr 2026 | Needham | Reiterated · Buy | 180.00 → 200.00 | +11.1% | 173.42 |
| 30 Apr 2026 | Deutsche Bank | — | 163.00 → 175.00 | +7.4% | 173.99 |
| 30 Apr 2026 | RBC Capital Srini Pajjuri | Reiterated · Sector Perform | 160.00 → 170.00 | +6.3% | 169.33 |
| 30 Apr 2026 | Oppenheimer Edward Yang | — | 180.00 → 200.00 | +11.1% | 169.06 |
| 30 Apr 2026 | Bernstein | Reiterated · Outperform | 183.50 → 187.50 | +2.2% | 181.62 |
| 30 Apr 2026 | Susquehanna | Reiterated · Neutral | 150.00 → 170.00 | +13.3% | 181.62 |
| 30 Apr 2026 | Morgan Stanley Shane Brett | — | 175.10 → 190.00 | +8.5% | 181.62 |
| 30 Apr 2026 | Jefferies | Reiterated · Buy | 185.00 → 200.00 | +8.1% | 181.62 |
| 21 Apr 2026 | UBS Timothy Arcuri | Reiterated · Neutral | 157.50 → 183.50 | +16.5% | 180.53 |
| 13 Mar 2026 | Wolfe Research Chris Caso | — | 150.00 → 180.00 | +20.0% | 142.65 |
| 13 Mar 2026 | Bernstein Stacy Rasgon | — | 175.00 → 183.50 | +4.9% | 143.94 |
| 30 Jan 2026 | RBC Capital Srini Pajjuri | Reiterated · Sector Perform | 155.00 → 160.00 | +3.2% | 148.23 |
| 30 Jan 2026 | Morgan Stanley | — | 169.40 → 175.10 | +3.4% | 152.38 |
KLA EPS and revenue estimates
Analysts expect KLA's EPS to grow 32.3% a year until 2029, faster than over the last 5 years (22.3% a year) and the last 3 years (14.9%).
Analysts expect KLA's revenue to grow 24.4% a year until 2029, faster than over the last 5 years (14.4% a year) and the last 3 years (9.0%).
Revenue
EPS
Does KLA beat earnings estimates?
On average, analysts' EPS estimate was 5.0% off the result, either way, and their revenue estimate 2.1%, over the last 12 quarters.
- EPS beats
- 108 / 134
- Revenue beats
- 106 / 120
- Average EPS surprise, last 12
- +5.0%
- Since
- January 1993
| Quarter | Report date | EPS estimate | Reported EPS | Surprise | Revenue estimate | Reported revenue | Surprise |
|---|---|---|---|---|---|---|---|
| Q1 FY2027 | 28 Oct 2026 | 1.19 | 1.22 | +2.5% | 4.04B | 4.14B | +2.3% |
| Q4 FY2026 | 28 Jul 2026 | 1.00 | 1.05 | +5.0% | 3.61B | 3.66B | +1.4% |
| Q3 FY2026 | 29 Apr 2026 | 0.92 | 0.94 | +2.5% | 3.37B | 3.42B | +1.2% |
| Q2 FY2026 | 29 Jan 2026 | 0.88 | 0.89 | +1.1% | 3.25B | 3.30B | +1.5% |
| Q1 FY2026 | 29 Oct 2025 | 0.86 | 0.88 | +2.3% | 3.17B | 3.21B | +1.2% |
| Q4 FY2025 | 31 Jul 2025 | 0.85 | 0.94 | +10.6% | 3.08B | 3.17B | +3.1% |
| Q3 FY2025 | 30 Apr 2025 | 0.81 | 0.84 | +3.7% | 3.01B | 3.06B | +1.8% |
| Q2 FY2025 | 31 Jan 2025 | 0.77 | 0.82 | +6.5% | 2.95B | 3.08B | +4.4% |
| Q1 FY2025 | 30 Oct 2024 | 0.70 | 0.73 | +4.1% | 2.75B | 2.84B | +3.4% |
| Q4 FY2024 | 25 Jul 2024 | 0.61 | 0.66 | +8.2% | 2.52B | 2.57B | +1.9% |
| Q3 FY2024 | 25 Apr 2024 | 0.49 | 0.53 | +8.2% | 2.31B | 2.36B | +2.3% |
| Q2 FY2024 | 25 Jan 2024 | 0.59 | 0.62 | +5.1% | 2.46B | 2.49B | +1.0% |
KLA stock price 2027–2031: scenarios
If KLA's earnings keep growing at the 31.1% a year analysts expect to FY2029, it would earn about 14.55 a share in FY2031. At the P/E it has traded at over the last five years (14.5 to 82.0) that is 210.43 to 1,193.26 a share, or 542.34 at its average P/E of 37.3. This is arithmetic on the analysts' estimates, not a prediction.
| Fiscal year | EPS | Bear | Base | Bull |
|---|---|---|---|---|
| FY2027 | 5.77 | 83.40 | 214.94 | 472.91 |
| FY2028 | 7.10 | 102.63 | 264.50 | 581.95 |
| FY2029 | 8.47 | 122.46 | 315.61 | 694.40 |
| FY2030 (extrapolated) | 11.10 | 160.53 | 413.73 | 910.28 |
| FY2031 (extrapolated) | 14.55 | 210.43 | 542.34 | 1,193.26 |
Each year's EPS is the analysts' consensus to FY2029; the years after continue its 31.1% a year. Bear, base and bull apply the lowest, average and highest P/E of the last five fiscal year ends (14.5, 37.3, 82.0).
Is KLA stock undervalued or overvalued?
KLA's P/E of 34.4 is above the middle of its 5-year range (11.9 to 84.7, median 29.0). Analysts expect faster growth than in recent years, which can explain part of the high P/E. Buyers pay about the usual price for each point of growth: a PEG of 1.1 on expected growth against 1.3 on its median P/E and past five years' growth. At its usual P/E (28.8 × EPS of 4.02), KLA's fair value is 115.68; the price, 138.21, is 19.5% above it. Its forward P/E, on the consensus for FY2027, is 24.0.
Fair value is the usual (median) P/E of the last five years times the earnings per share of the last twelve months; the ends of the bar are the same earnings at its lowest and highest P/E of those years (11.9 and 84.7). The price against its P/E range
- Price to earnings ratio (TTM)
- 34.35
- Five-year median P/E
- 28.95
- Five-year P/E range
- 11.9 – 84.7
- Forward P/E (FY2027)
- 23.96
- PEG ratio
- 1.11
- To the average target
- +58.5%
Most undervalued US stocks
| Stock | Price | Fair value | Upside |
|---|---|---|---|
| 99.090 | 195.09146Price 99.09244 | +96.9% | |
| 186.680 | 359.93270Price 186.68450 | +92.8% | |
| 213.670 | 405.66304Price 213.67507 | +89.9% | |
| 161.160 | 305.51157Price 161.16396 | +89.6% | |
| 42.225 | 79.0244Price 42.23157 | +87.1% | |
| 160.650 | 299.85225Price 160.65375 | +86.6% | |
| 108.445 | 201.41108Price 108.45248 | +85.7% |
Furthest below the fair value on each stock's page, updated every day.
